4036 participants
Immunogenicity and Safety Study of SK SARS-CoV-2 Recombinant Nanoparticle Vaccine (GBP510) Adjuvanted With AS03 (COVID-19)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-04-08
- Start Date:
- 2021-08-30
- Completion:
- 2023-10-02
Conditions
- Covid19
Interventions
- BIOLOGICAL
No Results Yet